Visceral leishmaniasis in children in the Yemen

Saudi Medical Journal

Volumn 22, Issue 6, 2001, Pages 516-519

  Haidar, Nassir A ^a   Diab, Abdul Baset L ^a   El Sheikh, Adel M ^a  

^a Saudi Hospital   (Yemen)

Author keywords

Children; Visceral leishmaniasis

Indexed keywords

PENTOSAN POLYSULFATE; STIBOGLUCONATE SODIUM;

ABDOMINAL DISTENSION; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CHILD; CLINICAL ARTICLE; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; LEUKOPENIA; MALARIA; MALE; PROSPECTIVE STUDY; VISCERAL LEISHMANIASIS; YEMEN;

ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; LEISHMANIASIS, VISCERAL; MALE; TREATMENT OUTCOME; YEMEN;

EID: 0034920007     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Al-Zahrani MA, Peters W, Evans DA, Smith V, Ching CI. Leishmania infecting man and wild animals in Saudi Arabia. Diversity of parasites causing visceral leishmaniases in man and dogs in the southwest. Trans R Soc Trop Med Hyg 1989; 83: 503-510.
2. WHO Expert Committee. The Leishmaniasis Geneva (Switzerland): WHO: 1984. Technical Report Series 701.
3. Hernandez PJ, Yebra BM, Jimenez ME, Sanz MC, Cuervas MV, Alonso PL et al. Visceral leishmaniases (Kala-azar) in solid organ transplantation: report of five cases and review. Clin Infect Dis 1999; 29: 918-921.
4. Delgado J, Macias J, Pineda JA, Corzo JE, Gonzalez-Moreno MP, de la Rosa R, et al. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniases in human immunodeficiency virus type-1-infected patients. Am J Trop Med Hyg 1999; 61: 766-769.
5. Martino L, Robert ND, Raffella G, Silvestro S, Franscesco R, Elio Castagnola et al. Treatment of visceral leishmaniases in children with liposomal amphotericin B. J Pediatr 1997; 131: 271-277.
6. Giri OP, Singh AN. Experience with amphotericin-B in sodium stibogluconate-unresponsive cases of visceral leishmaniases in north Bihar. J Assoc Physicians India 1994; 42: 690-691.
7. Jha TK, Sundar S, Thakur CP, Peter B, Juntra K, Christina P et al. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniases (see comments). N Eng J Med 1999; 341: 1795-1800.
8. Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, Carvalho FM et al. A prospective study of visceral leishmaniases in an endemic area of Brazil. J Infec Dis 1986; 154: 639-649.
9. Maru M. Clinical and laboratory features and treatment of visceral leishmaniases in hospitalized patients in northwestern Ethiopia. Am J Trop Med Hyg 1979; 28: 15-18.
10. Thakur CP, Bhowmick S, Dolfi L, Olliaro P. Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg 1995; 89: 219-223.
11. Zijlstra EE, Siddig AM, El-Hassan AM, Hofland HW, El-Toum I, Satti M et al. The treatment of kala-azar in the Sudan with sodium stibogluconate a randomized trial of three dosage regimens. Trans R Soc Trop Med Hyg 1993; 87: 307-309.
12. Benjamin B, Annobil SH, Bassuni WA. Diagnostic and management problems in childhood visceral leishmaniases in Southwest Saudi Arabia. Ann Trop Paediatr 1994; 14: 7-13.
13. Nyakundi PM, Wasunna KM, Rashid JR, Gachih MJ, Kirigi G, Muttunga J. Is one year follow-up justified in kala-azar post-treatment. East Afr Med J 1994; 71: 453-459.
14. Thakur CP, Sinha GP, Sharma V, Pandey AK, Kumar M, Verma BB. Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar. Indian J Med Res 1993; 97: 170-175.
15. Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson AD, Davidson RN. Epidemic visceral leishmaniases in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus stibogluconate alone. J Infect Dis 1993; 168: 715-720.
16. Elsheikh A, Mahgoub M, Al-Kebsi A. Visceral Leishmaniases in Children. The Medical Journal of Cairo University 1996; 64: 1007-1011.
17. Al-Orainy IO, Gasim IY, Singh LM, Badruddin I, Sylvester OU, Dhananjava G et al. Visceral leishmaniases in Gizan, Saudi Arabia. Annals of Saudi Medicine 1994; 14: 396-398.
18. Mehabresh MI, El-Mauhoub MM. Visceral leishmaniases in Libya review of 21 cases. Ann Trop Paediatr 1992; 12: 159-163.
19. Zijlstra EE, Ali MS, El-Hassan AM, El-Toum IA, Satti M, Ghalib HW. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults. J Trop Pediatr 1992; 38: 17-21.
20. Al-Juryan NA, Al-Ayed IH, Al-Nasser MN, Al-Mugeiren MM, Al-Mugeiren MM, Boohene AG, Al-Herbish AS. Visceral leishmaniases in infancy and childhood epidemiology and clinicopathological study of 63 cases in Al-Baha province, Saudi Arabia. J Trop Pediatr 1992; 38: 12-16.
21. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL. Epidemic visceral leishmaniases in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 1996; 124 : 664-672.